InsidersTradesSigma
健帆生物: directors' dealings · France · AMF
SZSE:300529FR·AMFMcap 15.7Bn€
Explore the full insider trade history of 健帆生物, a listed issuer based in France. Shares trade on FR FR, under the supervision of AMF. Market capitalisation: €15.7bn. The latest transaction was disclosed on 13 January 2023 (Sale). Among the most active insiders: 何小莲. All data is free.
6
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
4 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
18.97 €
Income statement
Revenue2.01 Bn€
Gross profit1.58 Bn€79% margin
Net income532.8 M€26.5% margin
Balance sheet & cash
Market cap15.71 Bn€
Total debt1.24 Bn€
Free Cash Flow548.6 M€
Last declaration on 13 January 2023
Declarations6 total
6 of 6 declarations